2008
DOI: 10.1182/blood.v112.11.1841.1841
|View full text |Cite
|
Sign up to set email alerts
|

Protein Kinase Cδ Differentially Regulates Platelet Functional Responses.

Abstract: Protein Kinase Cδ (PKCδ), a novel PKC isoform is expressed and activated in platelets downstream of PARs and GPVI receptors. In the current study, the role of PKCδ in regulating platelet functional responses was investigated using a pharmacological inhibitor, (δV1-1)TAT (a PKCδ inhibitor) in human platelets. These studies were further confirmed by a knockout approach using PKCδ+/+ and PKCδ−/− mice. In both human and murine platelets, PAR4-mediated dense granule secretions were inhibited, whereas GPVI-mediated … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
40
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 19 publications
(46 citation statements)
references
References 0 publications
5
40
1
Order By: Relevance
“…Mochly‐Rosen and colleagues [32,33] have proposed that there are unique RACKs for each PKC isoform, and that distinct cellular localizations of these RACKs would bring each PKC isoform into proximity with a distinct set of substrates. Peptides based on the RACK‐binding site, which thereby act as competitive inhibitors of RACK–PKC interactions, have been developed as isoform‐specific inhibitors for many cell types, including platelets [9,20,34].…”
Section: Pkc Activationmentioning
confidence: 99%
See 1 more Smart Citation
“…Mochly‐Rosen and colleagues [32,33] have proposed that there are unique RACKs for each PKC isoform, and that distinct cellular localizations of these RACKs would bring each PKC isoform into proximity with a distinct set of substrates. Peptides based on the RACK‐binding site, which thereby act as competitive inhibitors of RACK–PKC interactions, have been developed as isoform‐specific inhibitors for many cell types, including platelets [9,20,34].…”
Section: Pkc Activationmentioning
confidence: 99%
“…In contrast, Chari et al. [34] found enhanced GPVI‐dependent dense granule secretion in PKCδ −/− platelets, an effect replicated in human platelets by δ(V1‐1)‐TAT, a cell‐permeant peptide designed to block the interaction between PKCδ and its RACK. The reasons for this apparent difference are not clear.…”
mentioning
confidence: 93%
“…PKCδ has also been shown to negatively regulate GPVI induced platelet responses, as platelets from PKCδ deficient mice have enhanced aggregation and dense granule secretion in comparison to WT controls. This was also confirmed in human platelets using a cell permeable peptide that is designed to block the interaction of PKCδ and its RACK, δ(V1-1)-TAT (Chari et al, 2009). Contrasting reports however, also exist as other groups found no abnormality in GPVI-dependent dense granule secretion in PKCδ −/− platelets (Pula et al, 2006).…”
Section: Pkc Isoformsmentioning
confidence: 64%
“…Contrasting reports however, also exist as other groups found no abnormality in GPVI-dependent dense granule secretion in PKCδ −/− platelets (Pula et al, 2006). PKCδ deficient platelets generate larger thrombi when measured in vitro but not when measured in vivo (Gilio et al, 2010, Chari et al, 2009. The overall role of PKCδ has therefore been difficult to define, possibly as a consequence of diverse positive and negative regulatory roles played by this PKC isoform.…”
Section: Pkc Isoformsmentioning
confidence: 86%
“…In particular, protein C kinase isoforms α and β support granule secretion, 104 while others differentially affect granule release. [104][105][106]…”
Section: Mechanisms Of Platelet Granule Secretionmentioning
confidence: 99%